Kopelco launches new onslaught on Argentine condom market:
This article was originally published in Clinica
Argentina's leading condom manufacturer has launched the Tulipan Premium brand, in a bid to increase its domination of the national 132 million unit national market. Citing the innovative design of the Premium brand, the Buenos Aires firm (which is manufacturing the Spiral and Twist models under licence) aims to emulate the products' US success, as marketed by Trojan. "We hope the Premium will become a best-seller in Argentina, given the way its designs revolutionised the US and EU markets," said Kopelco managing director Jorge Agoff.
You may also be interested in...
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.
Russia says it will make the first deliveries of its $10-per-dose Sputnik V vaccine in January, while international regulators say vaccine trials should continue for as long as possible to generate longer-term evidence on their benefits and risks. A UK research body has stressed that drugs repurposed for COVID-19 also need to undergo thorough safety and efficacy testing as reports suggest the UK regulator could approve a vaccine within days.